Creatinine Test Market Size, Share, Growth, Trends, Revenue, Competitive Landscape, Forecast Report
The global creatinine
test market size is set to balloon till 2023 owing to rising incidence
of chronic kidney disease (CKD) and technological advances witnessed in various
diagnostic test kits. Market Research Future (MRFR)’s latest study reveals that
the market is predicted to grow at a 5.8% CAGR during the forecast period
(2018–2023). Government initiatives undertaken to create awareness of CKD among
patients is expected to positively impact the market. Product launches by new
and existing players to expedite the speed and accuracy of these tests can
offer new growth opportunities for the market.
Increased emphasis on quality healthcare is anticipated to
increase the healthcare budget of various nations, which in turn could bolster
market demand for creatinine tests. According to a report by the National
Center for Chronic Disease and Prevention, nearly 30 million U.S. residents
were afflicted with CKD in 2017. This disease was more commonly seen in women
more than men. Technologically advanced creatinine tests can help in lowering
these numbers considerably. Advances in point-of-care diagnostics facilitated
by automated analyzers, increasing diabetic populace, and presence of various
public and private healthcare organizations providing support for CKD
management can open up new avenues for the market.
Get Sample Report: https://www.marketresearchfuture.com/sample_request/4878
Global Market for Creatinine Tests – Segmental Analysis
MRFR’s report offers a detailed segmental analysis of the
market based on test type, product type, application, end-user, and region. By
type, the market has been segmented into blood test, urine test, and creatinine
clearance test. The blood test segment accounted for a large market share owing
to preference of blood tests to measure creatinine levels in the Americas. It
is expected to be lucrative for the market over the forecast period.
By product type, the market is segmented into consumables
and instruments. Consumables are further segmented into cartridges, urine test
strips, and others. Similarly, instruments are further segmented into clinical
analyzers and others. Clinical analyzers are segmented into benchtop and
handheld. The consumables segment is projected to register a 5.71% CAGR during
the forecast period, as tools such as urine test strips can provide an accurate
assessment of a patient’s urine level.
Major market applications include renal failure, kidney cancer,
glomerulonephritis, urinary tract obstruction, and others. The urinary tract
obstruction application segment is touted to capture a lion’s share of the
creatinine test market by the end of the forecast period owing to the urinary
tract being the most common area for blockage. The renal failure segment is
expected to grow at a 6.26% CAGR over the forecast period.
End-users covered in the report include research institutes,
diagnostic centers, hospitals & clinics, and others. The hospitals and
clinics segment is expected to contribute to the market owing to rise in
healthcare budgets of various nations.
Regional Outlook
The creatinine test market, on the basis of region, is
segmented into the Americas, Europe, Asia Pacific (APAC), and the Middle East
and Africa (MEA). The Americas region accounted for a large share of the market
in 2017. It will continue to dominate the market due to presence of
sophisticated healthcare infrastructure, adoption of latest diagnostic tests,
and incidence of CKD. Presence of various leaders of the healthcare industry
coupled with a massive healthcare budget is expected to facilitate market
growth. Favorable reimbursement policies can also influence patients in taking
these tests to catch kidney related disorders at a preventive stage.
APAC and Europe collectively accounted for 51% market share.
The APAC creatinine test market is driven by the large patient pool, rapidly
improving healthcare infrastructure, and adoption of latest customer-centric
healthcare models.
Global Market for Creatinine Test – Competitive Dashboard
Some of the key players profiled in the market report
include Abbott, URIT Medical, Nova Biomedical, Siemens AG, ARKRAY, Inc., The
Danaher Corporation, F. Hoffmann-La Roche AG, ACON Laboratories, Inc., Thermo
Fisher Scientific, Inc., Quest Diagnostics, Abcam plc, OPTI Medical Systems,
and others. Acquisitions, collaborations, and launch of new products are
strategies employed by these players to acquire a larger market share.
Approvals of new creatinine tests by respective regulatory agencies of various
nations are expected to propel the market to new heights.
Access Report @ https://www.marketresearchfuture.com/reports/creatinine-test-market-4878
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to
unravel the complexity of various industries through our Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR
team have supreme objective to provide the optimum quality market research and
intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats Research and Media
Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071
Comments
Post a Comment